Legislators Seek US FDA Input On Teva Proposed Opioid Settlement
Reps. McKinley and Kaptur ask commissioner Hahn about potential for shortages if Teva’s proposal to provide free opioid addiction treatment goes into effect. States are pushing for more money and stricter injunctive terms in settlement talks with manufacturers and distributers.
You may also be interested in...
Teva Sees Continued Legal Overhang As Q3 Sales Miss Mark
The company said it was optimistic about settling opioid litigation while still anticipating going to trial on price fixing.
Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
Teva Seeks Global Resolution Of Opioid Litigation As Bellwether Trial Is Halted
Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework.